Sales and Marketing

Showing 15 posts of 11527 posts found.

FDA extends Ranbaxy ban

January 27, 2014 Manufacturing and Production, Sales and Marketing API, FDA, Ranbaxy, toansa

India-based generic manufacturer Ranbaxy Laboratories has been dealt a further blow as the US regulator has banned more of its …

Shire replaces retiring chairman with former banker

January 24, 2014 Sales and Marketing Organogenesis, Shire, dermagraft, emmens, kilsby

Susan Kilsby is to be the new chairman at Shire and steps into Matthew Emmens’s role as he retires from …

Elderly denied cancer treatment on NHS

January 24, 2014 Sales and Marketing Cancer, Macmillan, NCIN, NHS, elderly

A UK charity is warning the NHS not to write off older cancer patients as ‘too old’ for treatment. With …

Mail backs down over NICE ‘champagne perks’ attack

January 24, 2014 Medical Communications, Sales and Marketing Daily Mail, NHS, NICE, UK, spending

The Daily Mail newspaper has backed down on an article it published earlier this month, which alleged that staff at …

NHS consults on loosening controls for Viagra

January 23, 2014 Sales and Marketing DH, ED, NHS, Pfizer, Sildenafil, viagra

The Department of Health is looking to make cheaper generic versions of Pfizer’s Viagra more widely available to patients with …

Danish government: ‘Sue pharma firms’

January 23, 2014 Sales and Marketing Actavis, Danish, Denmark, Lundbeck, celexa

A senior figure in Denmark’s government has said that local authorities should take legal action against pharma firms which put …

Novartis may axe 1,000 jobs in Diovan wake

January 23, 2014 Manufacturing and Production, Sales and Marketing Coartem, Diovan, Novartis, cuts

Novartis will shut down a plant in New York State that made heart drug Diovan and malaria treatment Coartem as …

Biotec Services appoints US head

January 23, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Clinical trials services firm Biotec Services International is looking to expand its presence in the US with the appointment of …

J&J profits up amid drug gains

January 23, 2014 Sales and Marketing FDA, J&J, JJ, Remicade, Zytiga, olysio, q4

Johnson & Johnson’s sales in the fourth quarter of 2013 rose 4.5% compared to the same period in the previous …

ABPI: NHS must explain drugs take-up

January 22, 2014 Sales and Marketing ABPI, NHS, NICE, Whitehead

The ABPI has called on the NHS to explain what it says is the ‘substantial variation’ in NHS patients’ access …

J&J tops social media leaderboard

January 22, 2014 Medical Communications, Research and Development, Sales and Marketing Facebook, IMS, J&J, JJ, Twitter, You Tube, social media

A new report has found that Johnson & Johnson is the most engaged pharma company when it comes to using …

Director appointments at Hanover

January 22, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hanover, harrison

Comms and PR consulting firm Hanover has announced senior management changes within its healthcare practice. Andrew Harrison (pictured) takes on …

NICE recommends Aubagio

January 22, 2014 Sales and Marketing Aubagio, EU, FDA, NICE, Sanofi, gilenya

NICE has recommended Genzyme’s multiple sclerosis pill Aubagio for use on the NHS. In final guidance the watchdog said Aubagio …

Herceptin biosimilar set for Indian market

January 21, 2014 Research and Development, Sales and Marketing Biocon, Herceptin, Roche, biosimilars, canmab

Biocon has said its generic version of Roche’s ageing breast cancer drug Herceptin will go on sale in India from …

AbbVie advances oncology drug

January 21, 2014 Research and Development, Sales and Marketing AbbVie, DNA, oncology, veliparib

AbbVie has begun a Phase III trial of its investigational compound veliparib in women with early-stage, triple-negative breast cancer.  This …
The Gateway to Local Adoption Series

Latest content